LU77245A1 - - Google Patents

Info

Publication number
LU77245A1
LU77245A1 LU77245A LU77245A LU77245A1 LU 77245 A1 LU77245 A1 LU 77245A1 LU 77245 A LU77245 A LU 77245A LU 77245 A LU77245 A LU 77245A LU 77245 A1 LU77245 A1 LU 77245A1
Authority
LU
Luxembourg
Application number
LU77245A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU77245A1 publication Critical patent/LU77245A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
LU77245A 1976-05-04 1977-05-03 LU77245A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619715 DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
LU77245A1 true LU77245A1 (en:Method) 1977-12-13

Family

ID=5977057

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77245A LU77245A1 (en:Method) 1976-05-04 1977-05-03

Country Status (17)

Country Link
JP (1) JPS52134011A (en:Method)
AT (1) AT362497B (en:Method)
AU (1) AU517395B2 (en:Method)
BE (1) BE854269A (en:Method)
CA (1) CA1077840A (en:Method)
DE (1) DE2619715A1 (en:Method)
DK (1) DK194477A (en:Method)
FR (1) FR2391733A1 (en:Method)
GB (1) GB1575545A (en:Method)
IE (1) IE44943B1 (en:Method)
IL (1) IL51989A (en:Method)
IT (1) IT1074325B (en:Method)
LU (1) LU77245A1 (en:Method)
NL (1) NL7704724A (en:Method)
NZ (1) NZ183980A (en:Method)
SE (1) SE7705070L (en:Method)
ZA (1) ZA772648B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
US5145844A (en) * 1987-07-23 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain
US5030733A (en) * 1987-07-23 1991-07-09 Hoechst-Roussel Pharmaceticals Incorporated Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NL7704724A (nl) 1977-11-08
JPS52134011A (en) 1977-11-09
BE854269A (fr) 1977-11-04
ATA313277A (de) 1980-10-15
CA1077840A (en) 1980-05-20
IT1074325B (it) 1985-04-20
SE7705070L (sv) 1977-11-05
FR2391733B1 (en:Method) 1980-03-07
AT362497B (de) 1981-05-25
AU2481877A (en) 1978-11-09
IE44943L (en) 1977-11-04
DK194477A (da) 1977-11-05
ZA772648B (en) 1978-04-26
DE2619715A1 (de) 1977-11-24
IL51989A0 (en) 1977-07-31
FR2391733A1 (fr) 1978-12-22
NZ183980A (en) 1980-04-28
AU517395B2 (en) 1981-07-30
IE44943B1 (en) 1982-05-19
GB1575545A (en) 1980-09-24
IL51989A (en) 1980-01-31

Similar Documents

Publication Publication Date Title
CH634453GA3 (en:Method)
DK121777A (en:Method)
DE2712660C3 (en:Method)
CS184186B1 (en:Method)
CS175342B1 (en:Method)
CS175339B1 (en:Method)
CH604410A5 (en:Method)
DD124447A1 (en:Method)
CH599840A5 (en:Method)
CH599910A5 (en:Method)
CH601164A5 (en:Method)
CH602082A5 (en:Method)
DD126860A1 (en:Method)
CH610749A5 (en:Method)
CH610785A5 (en:Method)
CH611653A5 (en:Method)
CH612326A5 (en:Method)
CH613530A5 (en:Method)
CH614372A5 (en:Method)
CH614957A5 (en:Method)
CH622663GA3 (en:Method)
CH595114A5 (en:Method)
CH591236A5 (en:Method)
CH400176A4 (en:Method)
BG23444A1 (en:Method)